loader
Please Wait
Applying Filters...

Metrochem API Private Limited Metrochem API Private Limited

X

Technical details about Fluoride Ion F-18, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Fluoride-18 anion, 18f-fluoride, (18f)-fluoride, Fluorine-18(1-), 67862-54-8, 4m4we5n2ge
Molecular Formula
F-
Molecular Weight
18.000937  g/mol
InChI Key
KRHYYFGTRYWZRS-BJUDXGSMSA-M
FDA UNII
4M4WE5N2GE

Sodium Fluoride F 18 Injection is a positron emitting radiopharmaceutical, no-carrier added. It contains radioactive fluoride F 18 that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging and is administered by intravenous injection. Its primary indication is for bone imaging. Increased deposition around joints can occur in arthritis and following trauma and increased deposition in bone has been noted around fracture sites, in osteomyelitis, fibrous dysplasia, spondylitis tuberculosa, and Paget's disease. No adverse reactions have been reported.
Fluoride ion f-18 is a Radioactive Diagnostic Agent. The mechanism of action of fluoride ion f-18 is as a Radiopharmaceutical Activity.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
fluorine-18(1-)
2.1.2 InChI
InChI=1S/FH/h1H/p-1/i1-1
2.1.3 InChI Key
KRHYYFGTRYWZRS-BJUDXGSMSA-M
2.1.4 Canonical SMILES
[F-]
2.1.5 Isomeric SMILES
[18F-]
2.2 Other Identifiers
2.2.1 UNII
4M4WE5N2GE
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Fluoride-18 Anion

2. 18f-fluoride

3. (18f)-fluoride

4. Fluorine-18(1-)

5. 67862-54-8

6. 4m4we5n2ge

7. Unii-4m4we5n2ge

8. Fluoride-18f

9. Fluoride-18

10. Fluoride F-18

11. Fluoride Ion F 18

12. Fluoride Ion, F-18

13. Fluoride (18f1-)

14. Fluorine-18 Ion(1-)

15. Dtxsid80218101

16. Db09398

17. Q27260079

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 18.000937 g/mol
Molecular Formula F-
XLogP30.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Exact Mass18.000937 g/mol
Monoisotopic Mass18.000937 g/mol
Topological Polar Surface Area0 Ų
Heavy Atom Count1
Formal Charge-1
Complexity0
Isotope Atom Count1
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

18F is used as a bone imaging agent to define areas of altered osteogenic activity. It has been indicated for back pain and otherwise unexplained bone pain, child abuse, abnormal radiographic or laboratory findings, osteomyelitis, trauma, inflammatory and degenerative arthritis, avascular necrosis. Osteonecrosis of the mandible, condylar hyperplasia, and metabolic bone disease are also among the indications for fluoride imaging.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Deposition of 18F fluoride in bone appears to be primarily a function of blood flow to the bone and the efficiency of the bone in extracting the 18F from the blood perfusing the bone. Increased fluorine F 18 ion deposition around joints can occur in arthritis or following trauma; increased deposition has also been documented in bone around fracture sites, in osteomyelities, fibrous dysplasia, spondylitis tuberculosa, Paget's disease, hyperstosis frontalis interna, myositis, ossificans, and in rapidly growing epiphyses. The tendency for fluorine F 18 ions to accumulate in the vicinity of primary and metastatic malignancy in bone has proven clinically useful in detection of such lesions


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
FLUORIDE ION F-18
5.2.2 FDA UNII
4M4WE5N2GE
5.2.3 Pharmacological Classes
Mechanisms of Action [MoA] - Radiopharmaceutical Activity
5.3 Absorption, Distribution and Excretion

Absorption

Following intravenous administration, Sodium Fluoride F 18 injection provides fluorine F 18 ions that rapidly equilibrate, primarily within the extracellular fluid space.


Route of Elimination

Fluorine F 18 ions are rapidly eliminated via the renal system. 20% or more of the fluorine F 18 ions are cleared from the body in the urine within the first 2 hours after intravenous administration.


Volume of Distribution

0.5-0.7 L/Kg


Clearance

Renal clearance for fluoride is 48-147 mL/min, depending upon urinary flow and pH.


5.4 Metabolism/Metabolites

First, the 18F- exchanges for an OH- ion on the surface of the hydroxyapatite matrix of bone and this is followed by migration of the 18F- into the crystalline matrix of the bone where it is retained until the bone is remodelled.


5.5 Biological Half-Life

110 min.


5.6 Mechanism of Action

18F-fluoride is a highly sensitive bone-seeking PET tracer used for detection of skeletal abnormalities. The uptake mechanism of 18F-fluoride has better pharmacokinetic characteristics (compared to other elements) including faster blood clearance and 2-fold higher uptake in bone. Uptake of 18F-fluoride reflects blood flow and bone remodeling.


Post Enquiry
POST ENQUIRY